Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mouse gut metagenome

ABSTRACT: Virome features in two mouse models of inflammatory bowel disease

PROVIDER: PRJNA938068 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23620013_1.fastq.gz	Fastqsanger.gz
	SRR23620013_2.fastq.gz	Fastqsanger.gz
	SRR23620014_1.fastq.gz	Fastqsanger.gz
	SRR23620014_2.fastq.gz	Fastqsanger.gz
	SRR23620015_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 372

Similar Datasets

mouse gut metagenome

Project description:Differing Complex Microbiota Alter Disease Severity of the IL-10-/- Mouse Model of Inflammatory Bowel Disease

| PRJNA384164 | ENA

Project description:Dog models of inflammatory bowel disease

| PRJEB13362 | ENA

human metagenomic

Project description:The colonic virome in inflammatory bowel disease

| PRJNA1004560 | ENA

human gut metagenome

Project description:Pediatric Inflammatory Bowel Disease Consortium Cohort

| PRJNA297124 | ENA

human gut metagenome

Project description:Human gut microbiome in inflammatory bowel disease

| PRJNA423297 | ENA

Gut Microbial Ecosystem Multiomics in Inflammatory Bowel Disease

Project description:Using multiple omics approaches to explore the effect of the gut microbial ecosytem on inflammatory bowel disease

2019-07-02 | MSV000084050 | MassIVE

Gut Microbial Ecosystem Multiomics in Inflammatory Bowel Disease

Project description:Using multiple omics approaches to explore the effect of the gut microbial ecosytem on inflammatory bowel disease

2019-04-05 | PXD008675 | Pride

Homo sapiens

Project description:Inflammatory bowel disease

| PRJNA87281 | ENA

2-DG protects mouse from DSS-induced inflammatory bowel disease

Project description:2-DG protects mouse from DSS-induced inflammatory bowel disease

| PRJNA705115 | ENA

Cross species transcriptomic signatures predict response to MK2 inhibition in mouse models of chronic inflammation

Project description:Translating observations from preclinical models to patients is one of the most pressing challenges in biomedical research. Part of the challenge derives from the necessity of studying preclinical therapeutic responses in genetically and environmentally homogenous mouse models, which exhibit less variability than genetically and environmentally heterogeneous humans. This problem is especially relevant for inflammatory bowel diseases (IBD), which are genetically complex and exhibit significant inter-patient heterogeneity in disease presentation and therapeutic response. Here, we show that mouse models of IBD exhibit variable responses to inhibition a MK2, a pro-inflammatory serine/threonine kinase, and that MK2 inhibition suppresses inflammation by targeting inflammatory monocytes and neutrophils. Using a computational approach (TransComp-R) that allows for cross-species comparison of transcriptomic features, we identified an IBD patient subgroup that is predicted to respond to MK2 inhibition and an independent preclinical model of chronic intestinal inflammation predicted to be non-responsive, which we validated experimentally. Thus, cross-species mouse-human translation approaches can help to identify patient subpopulations in which to deploy new therapies.

2021-01-08 | GSE164339 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data